September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Bone morphogenetic protein (BMP)-7 modulates TGFβ-induced epithelial-mesenchymal transition (EMT) of lens epithelial cells in a dose-dependent manner
Author Affiliations & Notes
  • Daisy Yao Shu
    Discipline of Anatomy & Histology, University of Sydney, Bosch Institute, Sydney, New South Wales, Australia
    Save Sight Institute, Sydney, New South Wales, Australia
  • Frank J Lovicu
    Discipline of Anatomy & Histology, University of Sydney, Bosch Institute, Sydney, New South Wales, Australia
    Save Sight Institute, Sydney, New South Wales, Australia
  • Footnotes
    Commercial Relationships   Daisy Shu, None; Frank Lovicu, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 2018. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Daisy Yao Shu, Frank J Lovicu; Bone morphogenetic protein (BMP)-7 modulates TGFβ-induced epithelial-mesenchymal transition (EMT) of lens epithelial cells in a dose-dependent manner. Invest. Ophthalmol. Vis. Sci. 2016;57(12):2018.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Epithelial-mesenchymal transition (EMT) of lens epithelial cells (LECs) is a key pathological mechanism underlying anterior subcapsular cataract (ASC) and posterior capsular opacification (PCO). Two members of the transforming growth factor-beta (TGFβ) superfamily, TGFβ and bone morphogenetic protein (BMP)-7 play significant but functionally distinct roles in EMT. While TGFβ is a potent inducer of EMT, recent studies have shown that BMP-7 can counteract the fibrogenic activity of TGFβ. The present study examines the modulating effect of BMP-7 on TGFβ-induced EMT in LECs.

Methods : Lens epithelial explants from 21-day-old Wistar rats were treated with TGFβ2 (200 pg/ml) alone or in combination with different doses of BMP-7 (1, 5, 10, 50ng/ml) for 48 hours. Expression levels of E-cadherin, alpha-smooth muscle actin (α-SMA) and phosphorylated downstream TGFβ signalling molecules, including extracellular-signal-regulated kinase (ERK) 1/2 were determined using immunofluorescence and western blotting. Cell morphology was examined using phase-contrast microscopy.

Results : TGFβ2 induced LECs to elongate and transdifferentiate into myofibroblastic cells positive for α-SMA, with concomitant reduction in E-cadherin. Co-treatment with TGFβ2 and BMP-7 impacted on this transdifferentiation response in a dose-dependent manner. The lowest dose of BMP-7 (1ng/ml) showed no noticeable difference to the TGFβ-alone treated explants while intermediate doses of BMP-7 (5 and 10ng/ml) reduced levels of α-SMA with retention of E-cadherin expression. A higher dose of BMP-7 (50ng/ml) did not impact on the TGFβ-induced transdifferentiation response, with similar levels of α-SMA expression to TGFβ-alone treated explants. Interestingly, this high dose of BMP-7 (50ng/ml) was accompanied by elevated levels of phosphorylated ERK1/2 compared to control and other TGFβ-treated explants.

Conclusions : Treatment with BMP-7 can abrogate TGFβ-induced EMT in rat lens epithelial explants in a dose-dependent manner. Understanding the complex interplay between TGFβ and BMP-7 signalling pathways may hold therapeutic promise in the prevention of ASC and PCO.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×